Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*-Reference-Cited by-同舟云学术

Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*

Published:2021-02-22 Issue:6 Volume:184 Page:1094-1105
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Graier T.¹^ORCID,Salmhofer W.¹,Jonak C.²,Weger W.¹,Kölli C.³,Gruber B.⁴,Sator P.G.⁵,Prillinger K.⁶,Mlynek A.⁷,Schütz‐Bergmayr M.⁸,Richter L.⁹,Ratzinger G.¹⁰,Painsi C.¹¹,Selhofer S.¹²,Häring N.¹³,Wippel‐Slupetzky K.¹⁴,Skvara H.³,Trattner H.²,Tanew A.²,Inzinger M.¹,Tatarski R.¹²,Bangert C.²,Ellersdorfer C.⁹,Lichem R.¹,Gruber‐Wackernagel A.¹,Hofer A.¹,Legat F.¹,Schmiedberger E.¹⁵,Strohal R.¹³,Lange‐Asschenfeldt B.¹¹,Schmuth M.¹⁰^ORCID,Vujic I.⁹,Hoetzenecker W.⁸,Trautinger F.⁶,Saxinger W.⁴,Müllegger R.³,Quehenberger F.¹⁵,Wolf P.¹^ORCID

Affiliation:

1. Department of Dermatology and Venereology Medical University of Graz Graz Austria

2. Department of Dermatology Medical University of Vienna Vienna Austria

3. Department of Dermatology and Venereology State Hospital Wiener Neustadt Austria

4. Department of Dermatology and Venereology Hospital of Wels‐Grieskirchen Wels‐Grieskirchen Austria

5. Department of Dermatology Hietzing Hospital Vienna Austria

6. Department of Dermatology and Venereology University Hospital St Pölten St Pölten Austria

7. Department of Dermatology Hospital of Elisabethinen Linz Austria

8. Department of Dermatology and Venereology Kepler University Hospital Linz Austria

9. Department of Dermatology and Venereology State Hospital of Vienna Rudolfstiftung Vienna Austria

10. Department of Dermatology, Venereology and Allergology Medical University of Innsbruck Innsbruck Austria

11. Department of Dermatology and Venereology State Hospital Klagenfurt Austria

12. Department of Dermatology and Allergology Paracelsus Medical University Salzburg Austria

13. Department of Dermatology and Venereology Federal Academic Teaching Hospital Feldkirch Austria

14. Health Center Vienna‐Nord Vienna Austria

15. Institute for Medical Informatics, Statistics, and Documentation Medical University of Graz Graz Austria

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19701

Reference44 articles.

1. Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)

2. Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)

3. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

4. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

5. Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of the Factors Affecting the Redefinition of Therapeutic Use in Metropolitan Cities during the Emerging and Re-emerging Pandemics;Romanian Journal of Military Medicine;2024-09-01

2. Investigating EGFR, BRAF, and RAS Mutations in Oral and Cutaneous Squamous Cell Neoplasms: A Preliminary Report on Romanian Patients;Romanian Journal of Military Medicine;2024-09-01

3. Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia;Journal of Dermatological Treatment;2024-08-05

4. A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?;Journal of the European Academy of Dermatology and Venereology;2024-07-30

5. Drug survival for biologics in psoriasis patients: real world evidence for Greece during the period 2016-2020;Clinical and Experimental Dermatology;2024-07-06